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For a cohort of 1189 male German former herbicide and insecticide workers with exposure to
polychlorinated dibenzo-p-dioxins and -furans (PCDD/F), we report an extended standardized
mortality ratio (SMR) analysis based on a new quantitative exposure index. This index characterizes
the cumulative lifetime exposure by integrating the estimated concentration of PCDD/F at every
point in time (area under the curve). Production department-specific dose rates were derived from
blood levels and working histories of 275 workers by applying a first-order kinetic model. These
dose rates were used to estimate exposure levels for all cohort members. Total mortality was
elevated in the cohort; 413 deaths yielded an SMR of 1.15 (95% confidence interval [Cl] 1.05, 1.27)
compared to the mortality of the population of Germany. Overall cancer mortality (n = 124) was
significantly increased (SMR = 1.41, 95% Cl 1.17, 1.68). Various cancer sites showed significantly
increased SMRs. The exposure index was used for an SMR analysis of total cancer mortality by
dose. For 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) a significant trend (p=0.01) for the SMRs with
increasing cumulative PCDD/F exposure was observed. The SMR in the first exposure quartile
(0-125.2 ng/kgxyears) was 1.24 (95% Cl 0.82, 1.79), increasing to 1.73 (95% Cl 1.21, 2.40) in the
last quartile (22503.0 ng/kgxyears). For all congeners combined as toxic equivalencies (TEQ) using
international toxic equivalency factors, a significant increase in cancer mortality was observed in the
second quartile (360.9-1614.4 ng/kg xyears, SMR 1.64; 95% Cl 1.13, 2.29) and the fourth quartile
(> 5217.7 ng/kgxyears TEQ, SMR 1.64, 95% Cl 1.13, 2.29). The trend test was not significant. The
results justify the use of this cohort for a quantitative risk assessment for TCDD and to a lesser
extent for TEQ. Environ Health Perspect 106(Suppl 2):655-662 (1998). http.//ehpnetl.
niehs.nih.gov/docs/1998/Suppl-2/655-662flesch-janys/abstract.html
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Objectives
Although there has been a considerable question whether the ubiquitous environ-
amount of research on the different bio- mental presence of this substance poses
chemical and health effects of2,3,7,8-tetra- any substantial health risk to humans is
chlorodibenzo-p-dioxin (TCDD) and still a matter of scientific and public con-
related compounds in the last 20 years, the troversy. One important concern stems
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from the observation that TCDD is a
strong carcinogen in different animals at
multiple sites (1). This is further emphasized
by the results ofseveral recent mortality
studies on occupationally (2-7) or environ-
mentally (8-10) exposed cohorts inwhich-
in contrast to earlier studies-the exposure
to TCDD was validated by measurements of
its concentration in biologic material.
Several attempts have been made to
estimate the magnitude ofthe cancer risk at
environmental levels (11) or to determine
a safe dose, i.e., that at which no adverse
effect is expected (12,13). Available risk
estimates were derived mainly from animal
carcinogenicity data, especially the Kociba
et al. (14) study. Results ofhuman studies
are not yet being used because ofa lack of
dose-response data on which to quantify
the magnitude ofrisk at certain doses.
A first approach to quantitative analysis
of a dose-response relationship on cancer
was published recently (15) for a cohort of
polychlorinated dibenzo-p-dioxins/furans
(PCDD/F)-exposed workers (4). An esti-
mate for the PCDD/F blood levels at the
end of employment was derived for the
whole cohort using blood-level data for a
subgroup of 190 workers. From these blood
levels production department-specific linear
average yearly increases in PCDD/F blood
concentrations (nanogram/kilogram/year)
were estimated by regressing the blood lev-
els at the end ofexposure (backcalculated
from the measured levels using a first order
kinetic assumption) on the duration of
work in different production departments.
These estimates were then used to calculate
the expected PCDD/F blood levels at the
end ofexposure for all cohort members by
multiplying the working times by the esti-
mates of the yearly increase. Using these
dose parameters a dose-response relation-
ship for cancer and exposure to PCDD/F
was demonstrated.
The use ofthese results to assess cancer
risk at background levels suffers from sev-
eral restrictions. First, the estimation proce-
dure used in this former paper (15) did not
take into account the elimination during
exposure, which results in a nonlinear
increase (Figure 1). Second, the course of
the working times in different departments
was not considered in the statistical model.
This raises the possibility that a worker
could have worked in a high-contamination
area first, followed by working a long time
in a department with low exposure. This
would assign the worker a low blood level
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Figure 1. Hypothetical course ofTCDD blood levE
based on excretion at the end ofexpo
Finally, the parameter blood level ai
end of exposure does not appear t
appropriate for a risk assessment for di(
with regard to background doses.
To illustrate the above situation, Fi
1 shows the course ofthe TCDD b
level for a hypothetical person with a
rate of 1 ng/kg/year up to 20 years o0
followed by a 10-year exposure to a
rate of 20 ng/kg/year measured 20 y
after the end ofexposure compared tC
course ofthe TCDD blood level for a
son with a dose rate of 1 ng/kg/year u
50 years of age. Several dose pararn
choices are available: the maximum
centration a person experienced over t
the level at the end ofexposure (not no
sarily identical with the maximum con
tration over time), or the integral ol
concentration over time (area under
curve). The area under the curve was
sen for risk assessment analysis becau
considers variations in the concentra
over time and reflects cumulative life
exposures to dioxins and furans (16).
This paper presents basic considerai
using the cohort for risk estimation
describes construction ofthe dose var
and a dose-response analysis relation
for cancer using the mortality ofthe p
lation ofGermanyas a reference. A det;
dose-response analysis taking into acc
several covariates and coexposure, espec
to beta-hexachlorocyclohexane (,B-H(
and an estimation ofcancer risk at envi
mental background levels are presente
Becheret al. (17).
Materials and Methods
The basic methods followed in this si
follow Manz et al. (4) and Flesch-Janj
Endofexposure. at the nearest time point for which data
wereavailable (22-24) were induded in the
estimation ofdose rates. First, measured con-
centrations ofeach congener diminished by
the median ofthe background concentration
were backcalculated to the end ofemploy-
ment under the assumption ofa first order
imeofmansuramnnt elimination process. A first order kinetic
equation was developed linking blood levels
andworking histories to produceproduction
department-specific dose rates for every con-
gener. Dose rates were used to estimate the
concentration ofevery congener at every
a. z 30 *5- Z ^ 50 point in time for all cohort members. The
cumulated PCDD/F levels expressed as
Age,years nanogram/kilogram blood fatxyears were
calculated by integration and used in the
els fortwo persons with different exposures. standardized mortality ratio (SMR) analysis.
Details of this modeling procedure are
tsure. al. (15). The cohort is composed of 1189 presented in "Appendix."
t the males employed on 1 January 1952 or later
o be for at least 3 months. Follow-up ended 31 culatlonofStdaIzed
oxins December 1992. Mortality Ratios
Standardized mortality ratios were
igure EimationofDoseRates calculated using the gender-, age-, and
blood Measurements ofPCDD/F levels in blood calendar year-specific mortality rates of
dose (n= 320) or adipose tissue (n= 62) were the German population for 1952 to 1992
fage available for 275 workers (39 females, 236 (Federal Statistical Agency, Germany, per-
dose males). Two or three measurements were sonal communication). Confidence intervals
years available for some workers, yielding a total (CIs) were calculated assuming the Poisson
the of382 blood samples. The blood levels were distribution for the observed cases. SMRs
per- determined by the ERGO laboratory were estimated for the total cohort and for
p to (Hamburg, Germany). Measurement meth- exposure levels categorized into four groups
ieter ods used are described in Stephens et al. according to the quartiles ofthe calculated
con- (18) and the adipose tissue concentrations area under the curve above background at
time, are described in Beck et al. (19). The the end ofthe follow-up. Person-years were
eces- concentrations are reported in nanogram/ calculated taking into account the course of
icen- kilogram blood oradipose fat. Toxic equiva- the person through the exposure classes.
f the lencies (TEQs) were calculated using the Trend tests were performed by linear regres-
r the international toxicity equivalency factors (I- sion ofthe SMRs on the geometric means of
cho- TEFs) (20). Working histories covering the theexposuregroupsweightedbythe number
se it duration ofemployment in 22 different ofobserved cases (25).
tion
time
tLions
and
iable
ship
opu-
ailed
ount
cially
_1H),
iron-
d by
tudy
ys et
departments were available for the entire
cohort. Categorization ofthe departments is
described in Flesch-Janys et al. (21). PCDDIFBloodLls
Only workers whose concentration at
the time of measurement exceeded the Blood- or adipose tissue-level data were
95% percentile ofthe German population available for 275 workers. Table 1 shows
Table 1. Description of the TCDD and higher chlorinated PCDD/F levels (nanogram/kilogram blood fat) calculated
asTEQM and TEQO, time between blood sample and end ofemploymentfor275workers.a
Males(n=236) Females(n=39) Total
Mean SD Min Max Mean SD Min Max Mean SD
TCDD 108.3 228.8 2.0 2252.0 110.5 281.9 6.0 1439.0 108.6 236.5
TEQO 142.0 184.0 9.7 1263.4 62.7 42.0 12.8 197.0 130.71 173.32
TEQM 247.5 339.3 11.7 2985.8 175.8 317.7 20.1 1636.0 237.3 336.6
TSEXIT 12.8 11.3 0.0 40.0 21.0 13.2 0.5 40.0 13.96 11.94
Abbreviations: Max, maximum; Min, minimum; SD, standard deviation; TEQM, international toxic equivalencies
with TCDD; TEQO, international toxic equivalencies without TCDD; TSEXIT, time since end of employment (years).
'f morethan one measurement was available the firstwas included in the calculation.
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the descriptive parameters for the PCDD/F entered the plant later (median 1967 vs and clean-up workers. These categories
levels. The arithmetic mean for TCDD 1959), and left the plant later (median were combined together from the main
was 101.3 ng/kg (minimum, 2.0; maxi- 1983 vs 1968). departments in the subsequent analysis.
mum, 2252 ng/kg). For the higher chlori- Workers with blood levels had longer . ofDose Rates
nated PCDD/F without TCDD calculated periods ofemployment than the workers
as international toxic equivalency (I-TEQ) without (median 9.2vs 3 years). Table 2 also Estimated dose rates for TCDD are shown
the mean was 89.3 (minimum, 5.0; maxi- shows the distribution ofworkers across pro- in Table 3. The highest dose rate was
mum, 1131.9). Table 2 characterizes the duction departments. In general an adequate obtained for the trichlorophenol department
group with available blood levels compared number ofworkers with blood levels were before the change in production process in
to the group ofworkers without blood available, but this was not always true- 1957 (3376.4 ng/kg blood fat/year). For
levels. The first group is slightly younger, especially with regard to administration the 2,4,5-trichlorophenoxyacetic acid
Table 2. Numberofworkers with andwithout data available on blood levels, age, and yearat entry, of end, and duration ofemployment in everyproduction department.
Workerswith blood-level data Workerswithout blood-level data Total
Variables no.a R SD RO.5 no.a SD x.5 no.a SD xO.5
Yearofbirth 275 1934 10.9 1934 1314 1928 14.4 1929 1589 1929 14.1 1930
Age atentry into plant - 30.9 10.0 29 - 32.9 11.9 31 - 32.5 11.6 30
Yearofentry into plant - 1965 9.0 1967 - 1961 8.2 1958 - 1961 8.5 1959
Yearof endofemployment - 1976 10.6 1983 - 1967 10.2 1966 - 1968 10.8 1968
Duration ofemployment - 10.8 8.8 9.2 - 5.9 7.7 2.3 - 6.8 8.1 3
Years in
2,4,5-T 46 6.5 7.2 3.9 127 3.6 5.5 1.2 173 4.4 6.1 1.7
Thermicdecomposition 17 8.5 6.2 8.9 15 3.5 4.6 1.3 32 6.2 6.0 3.2
TCP before 1957 21 1.3 1.2 0.7 75 0.9 1.1 0.4 96 0.9 1.1 0.5
TCPafter orduring 1957 35 6.2 6.3 3.6 92 3.9 4.8 1.8 127 4.5 5.4 2.3
Trichlorobenzene 18 2.1 2.3 1.6 80 1.3 2.4 0.4 98 1.4 2.4 0.5
Bromophos 15 9.1 6.1 9.2 34 3.6 4.0 2.3 49 5.3 5.3 3.4
HCH synthesis 33 4.6 5.8 1.65 86 4.1 6.6 0.8 119 4.2 6.4 1.0
Lindane 67 5.4 6.0 2.4 338 3.4 6.2 1.0 405 3.8 6.2 1.0
Formulation 59 3.9 5.6 1.5 384 2.5 4.5 0.8 443 2.7 4.7 0.9
Metal workers 27 12.2 8.8 9.5 64 6.4 7.6 3.0 91 8.1 8.4 4.1
Othermanual workers 20 9.2 8.1 5.8 41 6.5 7.3 3.7 61 7.4 7.6 4.4
Unskilled workers 26 0.9 2.9 0.2 152 0.9 2.5 0.2 178 0.9 2.6 0.2
Storage and transport 34 6.1 6.9 3.9 149 6.1 7.9 2.2 183 6.1 7.7 2.8
Laboratory 15 8.8 9.5 3.5 49 5.9 7.6 3.5 64 6.6 8.1 3.5
Engineers 10 9.7 7.9 8.9 35 8.6 8.0 5.0 45 8.8 7.9 6.2
Opiate 26 4.7 5.8 2.1 136 3.6 4.7 1.3 162 3.7 4.9 1.4
Kitchen 3 1.5 0.7 1.6 50 4.5 4.6 2.6 53 4.4 4.5 2.3
Administration 3 13.2 4.4 13.8 53 11.2 10.2 8.4 56 11.3 10.0 8.5
Plant security 5 17.5 7.3 14.4 24 6.5 5.7 6.0 29 8.4 7.2 6.7
Laundry 11 7.9 6.4 7 34 5.0 5.9 2.7 45 5.7 6.1 4.2
Clean-up administration 3 8.4 11.1 2.7 29 5.8 5.2 5.1 32 6.0 5.7 4.5
Others/unclassified 4 8.1 12.5 2.6 29 2.2 2.5 1.1 33 2.9 4.9 1.1
Abbreviations: 2,4,5-T, trichlorophenoxyacetic acid; TCP, trichlorophenol. aMultiple counts.
Table 3. Estimated dose rates (nanogram/kilogram blood fat/year) forTCDD and TEQs withoutTCDD)for PCDD/Fs, and j-HCH for different production departments.
Production department TCDD 95% Cl TEA 95% Cl P-HCH 95% Cl
Trichlorophenol before 1957 3376.4 2261.4-4491.4 90.0 15.1-164.8 14.6 4.1-25.1
2,4,5-Trichlorophenoxyacetic acid 154.6 102.5-206.7 33.8 7.8-59.8 1.7 -5.3-8.7
Trichlorophenol after orduring 1957 121.1 63.9-178.3 35.9 8.8-62.9 14.6 4.1-25.1
Manual workers 48.2 10.6-85.8 34.4 18.1-50.6 13.6 6.4-28.8
Bromophos 30.2 -6.8-64.2 15.1 1.4-28.8 10.4 -1.0-21.9
Hexachlorocyclohexane synthesis 30.2 -6.8-64.2 15.1 1.4-28.8 31.9 21.5-42.3
Formulation 30.2 -6.8-64.2 15.1 1.4-28.8 12.7 1.3-24.1
Unskilledworkers 30.2 -6.8-64.2 15.1 1.4-28.8 8.4 1.6-15.1
a-Decomposition/trichlorobenzene 6.7 -17.6-31.0 116.6 90.2-142.9 46.5 33.1-60.0
Lindane 6.7 -17.6-31.0 15.9 -5.2-36.9 17.7 10.6-24.8
Storage and transport 6.7 -17.6-31.0 29.2 2.0-56.4 8.4 1.6-15.1
Laboratory, engineers 6.7 -17.6-31.0 15.1 1.4-28.8 1.7 -5.3-8.7
Opiate (morphin production) 6.7 -17.6-31.0 15.1 1.4-28.8 8.4 1.6-15.1
Kitchen 6.7 -17.8-31.0 15.1 1.4-28.8 0 -
Laundry 6.7 -17.6-31.0 15.1 1.4-28.8 31.6 15.5-47.7
Administration, clean-up 0 - 0 - 0 -
Plantsecurity, others 0 0 1.7 -53-8.7
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(2,4,5-T) and trichlorophenol (TCP)
departments after 1957 the dose rates were
of the same order of magnitude (154.6
and 121.1 ng/kg blood fat/year). For man-
ual workers the estimate was 48.2. All
these estimates were significantly different
from zero (p<0.01). According to the
magnitude ofthe estimates in the model
with all 22 production departments (data
not shown), the other departments were
grouped into 2 groups, with estimated
dose rates of30.2 and 6.7 ng/kg/year. One
metalworker and two workers in the TCP
department, identified as oudiers byregres-
sion diagnostics, were excluded from the
final model. The dose rate estimates for
TCDD for metalworkers were decreased
from 184 ng/kg/year to 48.2 ng/kg/year by
this exclusion and that for the TCP depart-
ment before 1957 decreased from 3781.3
ng/kg/year to 3376.4 ng/kg/year. Except
for TCP, no production period-specific
differences in the estimated dose rate could
be identified for anydepartment. However,
10,000 -
1000
the data for different time periods were
sparse. No gender-specific effect or effects
ofshort durations ofemployment on dose
rates were seen. Datafor these latteranalyses
were also sparse.
Figure 2, which illustrates the fit ofthe
model, compares TCDD concentrations
at the end ofemployment calculated from
the measured levels (using "Appendix"
equation 3) with TCDD concentrations
predicted by the model. The symbols
indicate different lengths ofemployment.
The Spearman rank correlation coefficient
for comparison ofthe estimated with the
measured levels was 0.53.
Estimated dose rates for the higher
chlorinated congeners without TCDD
expressed as I-TEQs are shown in Table 3.
Highest dose rates were observed for the
thermic decomposition department (116.6
ng/kg/year; 95% CI 90.2, 142.9). TheTCP
production department yielded a dose rate
of90.0 ng/kg/year (95% CI 15.1, 164.8)
forthe time before 1957-mainly driven by
a high estimate for pentadioxin-and 35.9
ng/kg/year (95% CI 8.8, 62.9) thereafter.
For manual workers the estimate was 34.4
ng/kg/year (95% CI 18.1, 50.6). Estimates
for the otherdepartments ranged from 0 for
administration to 33.8 ng/kg/year for the
2,4,5-Tdepartment.
No dose rates were calculated for
2,3,7,8-tetrach hlorodibenzofuran,
1,2,3,7,8-pentachlorodibenzofuran, and
ortachlorodibenzofuran because ofthe lack
of a half-life estimate (26). However, the
blood levels ofthese congeners generally
were within the range ofthe ubiquitous
background levels and did not contribute
substantially to the total TEQs. The
Spearman rank correlation coefficients for
the higher chlorinated congeners varied
between 0.26 for heptadioxin and 0.60 for
1,2,3,4,7,8,9-heptafuran.
For fI-HCH the highest dose rate was
estimated for the thermic decomposition
department (46.5 pg/liter blood/year;
95% CI 33.1, 60.0), followed by the
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department for the synthesis of HCH
(31.9 pg/liter blood/year; 95% CI 21.5,
42.3). There was a high estimate for the
laundry department as well (31.6 pg/liter
blood/year; 95% CI 15.5, 47.7), but this
was based on only four measurements.
Estimates for the other departments
ranged between 0 for administration and
17.7 pg/liter blood/year for the lindane
department. The Spearman rank correla-
tion coefficient was 0.72 (p<0.01). Figure
3 shows the estimated time/concentration
curve for one ofthe cohort members.
StandardizedMortlity
RatioAnalysis
Table 4 shows SMRs for different causes of
death for the total cohort. Total mortality
was significantly elevated (SMR 1.15; 95%
CI 1.05, 1.27). A total of 124 cancer deaths
yielded a significantly elevated SMR (1.41;
95% CI 1.17,1.68) produced by elevations
ofseveral localizations. Statistically signifi-
cant elevations were observed for rectum
(SMR 2.3; 95% CI 1.05, 4.37), lung (1.51;
95% CI 1.07, 2.08), other respiratory can-
cers indudingmesotheliomas (1.71; 95% CI
1.24, 2.29), and all hematopoietic and lym-
phatic cancers (2.16; 95% CI 1.11, 3.77),
especially lymphosarcoma (3.73; 95% CI
1.20, 8.71). The SMRs for several other
localizations were nonsignificantly increased;
these induded the esophagus (2.36; 95% CI
0.76, 5.50), larynx (3.10; 95% CI 0.83,
7.94), and prostate (1.47; 95% CI 0.67,
200-
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Figure 3. Estimated concentration over time for TCDD
and TEG for one cohort member.
2.78). Estimates for several localizations were
below 1; however, with the exception of
colon cancer, these generally were not local-
izations with large numerical impacts on
total cancer mortality.
The SMR for cardiovascular diseases was
slightly nonsignificandy elevated (1.06; 95%
CI 0.90, 1.24). No increase was observed
for nonmalignant respiratory diseases or for
digestive diseases. The SMR for unnatural
causes (accidents and suicides) was 1.79
(95% CI 1.35, 2.33). There were 24 ill
defined or unknown causes of death, yield-
ing an SMRof2.59 (95% CI 1.66, 3.85).
Table 5 shows the results of the SMR
analysis using the estimated integrated
TCDD concentration until the end of
follow-up as dose parameter. A U-shaped
relation between dose and mortality was
observed for all causes of death. The linear
trend test was not significant. The SMR
for all cancer combined was 1.24 (95% CI
0.82, 1.79) for the first quartile (up to
125.2 ng/kg blood fatxyear) and increased
from 1.34 in the second and third to 1.73
(95% CI 1.21, 2.40) in the fourth quartile
(more than 2503.0 ng/kgxyear). The lin-
ear trend test was significant (p=0.013).
No trend was observed for lung cancer or
for all hematopoietic and lymphatic can-
cers combined. Total TEQs also showed
a U-shaped relation to total mortality
(Table 6). For total cancer the SMR in
the first quartile (up to 360.9 ng/kgxyear)
was 1.07 (95% CI 0.69, 1.58). A signifi-
cant increase was observed in the second
quartile (1.64; 95% CI 1.13, 2.29), which
ranged up to 1614.4 ng/kgxyears. The
Table 4. Standardized mortality ratios for selected causes of death using the mortality rates of the population of
Germany as reference.
ICD-9 Cause of death 0 E SMR 95% Cl
10-999 All causesa 413 357.71 1.15 1.05-1.27
10-139 Infections 2 4.91 0.41 0.05-1.47
140-208 Malignancies of: 124 88.12 1.41 1.17-1.68
140-149 Buccal cavity, pharynx 3 2.17 1.38 0.28-4.04
150 Esophagus 5 2.12 2.36 0.76-5.50
151 Stomach 13 10.88 1.19 0.64-2.04
153 Colon 2 6.21 0.32 0.04-1.16
154 Rectum 9 3.91 2.30 1.05-4.37
155 Liver, gall bile 2 2.77 0.72 0.09-2.61
157 Pancreas 3 3.88 0.77 0.16-2.26
161 Larynx 4 1.29 3.10 0.83-7.94
162 Lung 38 25.11 1.51 1.07-2.08
162-165 Respiratory 44 25.75 1.71 1.24-2.29
170 Bone 0 0.49 0.00
171 Softtissue 0 0.33 0.00
172-173 Skin 2 1.02 1.96 0.24-7.08
174-175 Breast 0 0.12 0.00
185 Prostate 9 6.14 1.47 0.67-2.78
188 Bladder 2 2.90 0.69 0.08-2.49
189 Kidney 5 2.57 1.95 0.63-4.54
191-192 Brain 3 1.57 1.91 0.39-5.58
193 Thyroid 0 0.31 0.00
194 Endocrine gland 1 0.10 10.00 0.25-55.72
195 Ill-defined 5 4.25 1.18 0.38-2.75
200-208 Lymphatic and hematopoietic cancer 12 5.56 2.16 1.11-3.77
200 Lymphosarcoma 5 1.34 3.73 1.20-8.71
201 Morbus Hodgkin 0 0.79 0.00
203 Multiple myelomas 3 0.70 4.29 0.88-12.52
204-208 Leukemia 4 2.63 1.52 0.41-3.89
290-319 Psychiatric 3 3.57 0.84 0.17-2.46
320-389 Nervous system 7 8.26 0.85 0.34-1.75
390-459 Cardiovascular 156 146.92 1.06 0.90-1.24
410-414 Ischemic 76 78.17 0.97 0.77-1.22
430-438 Cerebrovascular 24 32.07 0.75 0.48-1.11
460-519 Respiratory 13 23.34 0.56 0.30-0.95
520-579 Digestive 23 24.99 0.92 0.58-1.38
780-799 IlIl definedb 24 9.28 2.59 1.66-3.85
800-999 Unnatural causes 56 31.23 1.79 1.35-2.33
Abbreviations: E, expected number of cases; ICD-9, Intemational Classification ofDiseases, Ninth Revision(World
Health Organization, Geneva); 0, observed. ain contrast to an earlier paper[Flesch-Janys et al. (15)1, one cause of
death was not counted in the cause-specific SMR analysis because of unreliable cause-of-death statistics for age
groups >85years. bIncluding unknown causes of death.
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Table 5. Standardized mortalityratios forselected causes ofdeath byTCDD quartiles above background levels.
ICD-9 Cause ofdeath TCDD quartilea 0 E SMR 95% Cl p, trend
000-E999 All causes 120 94.80 1.27 1.05-1.51
11 107 89.20 1.20 0.98-1.45
IIl 83 93.26 0.89 0.71-1.10
IV 103 80.46 1.28 1.04-1.55
All 413 357.72 1.15 1.05-1.27 0.66
140-208 Total cancer 28 22.57 1.24 0.82-1.79
11 29 21.64 1.34 0.90-1.92
Ill 31 23.17 1.34 0.91-1.90
IV 36 20.75 1.73 1.21-2.40
All 124 88.12 1.41 1.17-1.68 0.01
162 Lung cancer 10 6.39 1.56 0.75-2.88
11 10 6.13 1.63 0.78-3.00
IlIl 8 6.56 1.22 0.53-2.40
IV 10 6.03 1.66 0.79-3.05
All 38 25.11 1.51 1.07-2.08 0.61
200-208 Hematopoietic and 4 1.57 2.55 0.69-6.52
lymphaticcancer II 3 1.36 2.21 0.45-6.45
Ill 4 1.38 2.90 0.78-7.42
IV 1 1.25 0.80 0.02-4.46
All 12 5.56 2.16 1.11-3.77 0.17
81,0<TCDD<125.2; 11, 125.2<TCDD<627.1; III, 627.1 <TCDD<2503.0; IV, 2503.0<TCDD.
Table6.Standardized mortality ratios forselected causes ofdeath byTEQ quartiles above background levels.
ICD-9 Cause ofdeath TEQquartilea 0 E SMR 95% Cl p, trend
000-E999 All causes 121 97.92 1.24 1.03-1.48
11 100 84.99 1.18 0.98-1.43
IlIl 92 94.86 0.97 0.78-1.19
IV 100 79.95 1.25 1.02-1.52
All 413 357.71 1.15 1.05-1.27 0.67
140-208 Total cancer 25 23.32 1.07 0.69-1.58
11 34 20.78 1.64 1.13-2.29
Ill 31 23.26 1.33 0.91-1.89
IV 34 20.76 1.64 1.13-2.29
All 124 88.12 1.41 1.17-1.68 0.48
162 Lung cancer 8 6.62 1.21 0.52-2.38
11 13 5.92 2.20 1.17-3.76
IlIl 6 6.55 0.92 0.33-1.99
IV 11 6.02 1.83 0.91-3.27
All 38 25.11 1.51 1.07-2.08 0.85
200-208 Hematopoietic and 5 1.64 3.05 0.98-7.11
lymphatic cancer 11 2 1.33 1.50 0.18-5.43
Ill 3 1.35 2.22 0.46-6.49
IV 2 1.23 1.63 0.20-5.87
All 12 5.56 2.16 1.11-3.77 0.44
l, 0<TEQ<360.9; II, 360.9<TEQ<1614.4; III, 1614.4<TEQ<5217.7; IV, 5217.7< I-TEQ.
estimate for the third quartile was 1.33
(95% CI 0.91, 1.89) and it increased to
1.64 (95% CI 1.13, 2.29) in the fourth
quartile (>5217.7 ng/kgxyears). The linear
trend test for all cancer was not significant
(p=0.48). Thiswas also true forlung cancer
andhematopoietic andlymphaticcancers.
Discussion
A significant 40% increase in total cancer
mortalitywas observed for thewhole cohort
compared to that for the German popula-
tion. Thus, cancer mortality increased in
the 3 additional years offollow-up (1989 to
1992) from 1.24 to 1.41. This elevation in
total cancer mortality was not restricted to
one localization. Significant increases were
observed for lung, all respiratory cancers,
rectum, and hematopoietic and lymphatic
cancers, especially lymphosarcomas, which
belong to the non-Hodgkin's type oflym-
phomas. No case ofsoft-tissue sarcoma was
observed, although 0.33 were expected.
Available blood levels revealed the cohort
had substantial exposure to TCDD. Mean
concentration at the time ofmeasurement
was 101.3 ng/kg TCDD, with a maximum
level of2252 ng/kg. There was also substan-
tial exposure to higher chlorinated con-
geners, with a mean of89.3 ng/kg TEQ
(without TCDD) and a maximum of
1131.9 ng/kg.
Estimated dose rates derived from these
measurements allowed estimation ofthe
maximal concentration for each worker
during his or her period ofobservation.
For TCDD a mean of340.5 ng/kg was
observed. Highest concentrations were esti-
mated forthreeworkerswithvalues between
10,000 and 13,000 ng/kg. The mean ofthe
estimated maximum concentrations fortotal
I-TEQ was 473.5 ng/kg, with a maximum
value of13,179 ng/kgI-TEQ.
With the exception of ,-HCH [see
Becher et al. (17)], other potential con-
founders like smoking habits and exposure
to other carcinogenic or suspected carcino-
genic substances could not be addressed
directly. With regard to smoking, we
showed that blood-level estimates were not
correlated with smoking status for a sub-
group ofworkers (15) for whom these data
were available. In addition, calculating total
cancer mortality without lung cancer cases
for the TCDD exposure groups yielded an
even more pronounced trend (SMRs for
TCDD quartiles I-IV: 1.11, 1.23, 1.38, and
1.77, calculated from Table 5) in contrast to
what one would expect ifsmoking had been
a strong confounder of the observed
dose-response relationship. We showed that
exposure to other carcinogens occurred
mainly in departments with low exposure to
TCDD [Flesch-Janys etal. (15)].
An important question in dose-response
analysis is whether exposure measurements
reflect the exposure ofall cohort members
with sufficient accuracy. First, the relation-
ships between the production department-
specific estimates are in good agreement
with the expectation from the chemistry of
the production processes and the available
data on the contamination ofproducts,
buildings, and waste. The highest dose rates
for TCDD were obtained for the 2,4,5-T
and 2,4,5-TCP departments, as expected.
Measurements indicate contamination of
2,4,5-T acid in the parts per million range
in former years, whereas in waste from
2,4,5-T production concentrations up to
3360 pg/kg TCDD were detected. In
contrast, the octachlorodibenzodioxin
concentrations ofup to 7200 pg/kg were
comparably low. Conversely, the highest
dose rates for the higher chlorinated con-
geners were obtained for the thermic
decomposition department, where measure-
ments of smelting showed hexa- and
octadioxin concentrations up to 32x 106
pg/kg but only 500 pg/kg TCDD (21).
For this department the highest dose
rates for the higher chlorinated congeners
were detected.
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For some departments we observed
positive but nonsignificant dose rates. We
were aware of the possibility of overfit-
ting the model; however, the estimates
were all in good agreement with a priori
knowledge of exposure levels so we
decided to use them. No information was
available on job duties within the depart-
ments or on potential accidental expo-
sure. These factors could yield some
additional variations.
Another critical point is the assump-
tion of a first order elimination kinetic.
Available human data (26,27) indicate
that this assumption is reasonable, at least
in the observed dose range. No human
data were available on the form of
absorption kinetics that could have been
considered in the exposure model. There
were few workers with short durations of
employment and comparably high levels
ofPCDD/F. Whether this could be attrib-
uted to individual exposure histories, i.e.,
accidental or time/concentration-depen-
dent modulation of PCDD/F absorption,
remains unclear.
SMRanalysis revealed asignificant trend
for total cancer mortality with increasing
estimated cumulated TCDD levels. This
result is supported by a study from the
Netherlands (28) and the latest results on
cancer mortality within an accidental
German cohort (5). The dose estimates in
theNetherlands studyindirectly support the
dose-rate estimation presented in this paper
in that the Netherlands results were roughly
in the same order ofmagnitude, though a
different estimation technique was used. For
total TEQthe trend was not as pronounced
as forTCDD.
In summary, we observed an elevated
risk of total cancer mortality in a cohort
with high exposure to PCDD/F. A dose-
dependent effect was observed for esti-
mated TCDD levels on total cancer
mortality by SMR analysis using an index
that characterizes cumulated exposure to
TCDD and the higher chlorinated con-
geners. We conclude that use of these
data for quantitative cancer risk assessment
is justified.
Appendix
Estimation ofthe dose rates was performed
in the following steps:
1. For every congener only those indi-
viduals were included whose blood levels
exceeded the 95% CI of the German
background concentrations (22-24).
2. The median of the background
concentration was substracted from the
measured levels.
3. Assuming a first order kinetic
model for every individual included the
background-adjusted levels y,, taken at
time tM(n) were backcalculated to the date
of exit from the plant tA(n) according to
the formula:
Yn(tA(,)) =Y.(tM(.))
xexp[2(n)x(tM(n) -tA(n))]
where ndenotes the individuals (n= 1,...,N)
(N=275). The decay parameters A(n) for
the different congeners and for P-HCH
were derived from the results ofa half-life
study within a subgroup of n=48 workers
with two or three measurements at different
time points (26,29). Decay rates adjusted
for age andpercentbodyfatwere used.
4. To estimate the department-specific
dose rates, alinear regression model without
an interceptwas specified as follows:
E(y,(tA(J))) = n = 1,.N
with
fi _1 -exp(-A(tAij-tE,)]
xexp[-A(tA(.) -tAij)]
where ji, i=1,...,m denotes the dose rate for
the m different departments where aworker
couldhaveworked up to ktimes. Thework-
ing time () in the department (i) started at
time tEq and ended at tA... In this model it
was assumed that the dose rate for a specific
department was constant over time.
5. To identify relevant departments the
following procedure was performed: First,
for every congener, models, including all
departments separately, were fitted. Second,
the potential impacts ofgender and different
production periods were tested by including
appropriate dummy variables. Third, three
outliers were identified by regression diag-
nostics and excluded (30). These observa-
tions changed the effect estimate by more
than 10%. The exclusion was further sup-
ported by industrial hygiene data. Fourth,
departments for which estimates showed
large standard errors were combined into
two groups. This grouping was guided by
the magnitude ofthe estimates and a priori
plausibility considerations on the expected
exposure to PCDD/F from the chemistry of
the processes. For all higher chlorinated con-
geners except PCDD, the same grouping
was used. Fifth, the Spearman rank correla-
tion coefficient was used as a descriptive
measure for the model fit because the
Pearson correlation coefficient was affected
bysomelargeresiduals.
6. The estimated dose rates pi were
then used to estimate the blood level at
every point in time as follows:
y(t)= 2 (1-exp-A(tA t
-tEq
xexp(-At-tA..))I{t)tAJ (
+
(1
-exp(-A(tAi
-tEi)))
XIEij<t<ctAij}(t
Irepresents the indicator function.
7. The area under the curve was calcu-
lated as
t
D(t)= Jy(x)dx,
tE
where tE denotes the date of entry into
the plant and tthe date ofend ofobserva-
tion, which can be solved by elementary
integration rules.
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